SMITHKLINE BEECHAM (INVESTMENTS) LIMITED

Accounts Submitted 29 May 2025

Confirmation Statement Submitted 8 Sept 2025

Net assets £518.00M £19.42M 2024 year on year

Total assets £529.75M £24.67M 2024 year on year

Total Liabilities £11.75M £5.25M 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Credit Report

Discover SMITHKLINE BEECHAM (INVESTMENTS) LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£518.00M

Increased by £19.42M (+4%)

Total Liabilities

£11.75M

Increased by £5.25M (+81%)

Turnover

N/A

Employees

N/A

Debt Ratio

Increased by 1 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 25 resigned

Show resigned officers

						Status
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	28 Feb 2001	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-secretary	United Kingdom	Unknown	—	18 Jan 2002	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	28 Feb 2001	Active
Laura Guittard	Director	British,french	United Kingdom	60	11 Jan 2022	Active

Shareholders

Shareholders (2)


Smithkline Beecham Limited	55.0%	800,001	Ordinary	6 Oct 2015
Glaxosmithkline Biologicals S.a	45.0%	653,541	Ordinary	6 Oct 2015

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Setfirst Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors

Smithkline Beecham Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 50 To 75 Percent
Voting Rights 50 To 75 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

SETFIRST LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

SMITHKLINE BEECHAM LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

SMITHKLINE BEECHAM (INVESTMENTS) LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
8 Sept 2025	Confirmation Statement	Confirmation statement made on 2025-09-08 with no updates	View(3 pages)
29 May 2025	Accounts	Annual accounts filed	View(344 pages)
29 May 2025	Other	Notice of agreement to exemption from audit of accounts for period ending 31/12/24	View(1 page)
29 May 2025	Other	Audit exemption statement of guarantee by parent company for period ending 31/12/24	View(2 pages)
29 May 2025	Accounts	Annual accounts made up to 2024-12-31	View(14 pages)